Search filters

List of works by Francisco Pérez-Miralles

Adding brain volume measures into response criteria in multiple sclerosis: the Río-4 score

scientific article published on 25 November 2020

An observational study of the effectiveness and safety of natalizumab in the treatment of multiple sclerosis.

scientific article published in March 2011

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.

scientific article published on 10 April 2017

Bilateral third nerve palsy with pupil involvement as the first manifestation of multiple sclerosis

scientific article published on 01 December 2011

Brain Atrophy in Relapsing Optic Neuritis Is Associated With Crion Phenotype

scientific article published on 01 November 2019

Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume Dynamics

scientific article

CSF chitinase 3-like-1 association with disability of primary progressive MS

scientific article published on 01 July 2020

Clinical evaluation of rituximab treatment for neuromyelitis optica

scientific article published on 11 November 2014

Clinical experiences with cannabinoids in spasticity management in multiple sclerosis.

scientific article

Clinical impact of early brain atrophy in clinically isolated syndromes

scientific article published on 07 May 2013

Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis

scientific article published on 23 September 2019

Daclizumab in multiple sclerosis

scientific article published in April 2018

Development and pilot phase of a European MS register

scientific article published on 05 May 2010

Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients

scientific article published on 07 June 2018

Dyschromatopsia in multiple sclerosis reflects diffuse chronic neurodegeneration beyond anatomical landmarks

scientific article published on 12 October 2020

Early brain pseudoatrophy while on natalizumab therapy is due to white matter volume changes.

scientific article

Early experience with compassionate use of 2 hydroxypropyl-beta-cyclodextrin for Niemann-Pick type C disease: review of initial published cases

scientific article published on 2 February 2017

Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study

scientific article published on 21 May 2018

Incidence of and Risk Factors for Neurologic Complications After Heart Transplantation

scientific article published on 01 November 2005

Intrathecal somatic hypermutation of IgM in multiple sclerosis and neuroinflammation

scientific article

Longitudinally extensive transverse myelitis with AQP4 antibodies revealing ovarian teratoma

scientific article published on 27 July 2013

Neuronal antigens recognized by cerebrospinal fluid IgM in multiple sclerosis.

scientific article

Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies.

scientific article published in April 2018

Perception of stigma in patients with primary progressive multiple sclerosis

scientific article published on 01 April 2019

Peripheral nerve hyperexcitability: A clinical and immunologic study of 38 patients

scientific article published on 01 January 2011

Predictive value of early brain atrophy on response in patients treated with interferon β

scientific article published on 2 July 2015

Progressive Demyelination in the Presence of Serum Myelin Oligodendrocyte Glycoprotein-IgG: A Case Report.

scientific article

Reader response: Intrathecal IgM production is a strong risk factor for early conversion to multiple sclerosis

scientific article published on 01 August 2020

Search for specific biomarkers of IFNβ bioactivity in patients with multiple sclerosis.

scientific article

Significant clinical worsening after natalizumab withdrawal: Predictive factors

article

Silent Progression or Bout Onset Progressive Multiple Sclerosis?

scientific article published on 12 July 2019

Treatment of relapsing-remitting multiple sclerosis with fingolimod in routine clinical practice

scientific article published in May 2017

Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing-remitting multiple sclerosis is effective and safe

scientific article published on 19 January 2019

Use of 2 hydroxypropyl-beta-cyclodextrin therapy in two adult Niemann Pick Type C patients

scientific article published on 26 April 2016

Paulina is supported by:

About Paulina

Help